Genentech Submits New Drug Application for Cobimetinib with Zelboraf for Treating Advanced Melanoma

Roche subsidiary pursues new form of melanoma treatment by combining cobimetinib and Zelboraf after coBRIM study showed the combination of the two drugs yielded desirable results.